Phosphodiesterase Inhibitors in Chronic Obstructive Pulmonary Disease

被引：1
作者：
Oba, Yuji [1 ]
机构：
[1] Univ Missouri, Columbia, MO 65211 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 188卷 / 11期
关键词：
THEOPHYLLINE;
D O I：
10.1164/rccm.201303-0510LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1366 / 1366
页数：1
相关论文
共 7 条
  • [1] Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease
    Cyr, Marie-Christyne
    Beauchesne, Marie-France
    Lemiere, Catherine
    Blais, Lucie
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (01) : 40 - 50
  • [2] GUYATT GH, 1987, AM REV RESPIR DIS, V135, P1069
  • [3] Pharmacoeconomic evaluation of COPD
    Hilleman, DE
    Dewan, N
    Malesker, M
    Friedman, M
    [J]. CHEST, 2000, 118 (05) : 1278 - 1285
  • [4] A RANDOMIZED, CONTROLLED TRIAL OF THEOPHYLLINE IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    MURCIANO, D
    AUCLAIR, MH
    PARIENTE, R
    AUBIER, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (23) : 1521 - 1525
  • [5] Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Oba, Yuji
    Lone, Nazir A.
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 7 (01) : 13 - 24
  • [6] Ram F S, 2002, Cochrane Database Syst Rev, pCD003902, DOI 10.1002/14651858.CD003902
  • [7] Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease GOLD Executive Summary
    Vestbo, Jorgen
    Hurd, Suzanne S.
    Agusti, Alvar G.
    Jones, Paul W.
    Vogelmeier, Claus
    Anzueto, Antonio
    Barnes, Peter J.
    Fabbri, Leonardo M.
    Martinez, Fernando J.
    Nishimura, Masaharu
    Stockley, Robert A.
    Sin, Don D.
    Rodriguez-Roisin, Roberto
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (04) : 347 - 365
1